However, multivariate Cox regression on patient outcomes, including adjustments for tumor size, grade, and lymph node stage, has revealed that FOXP3 TILs are not an independent prognostic factor in HR+ breast tumors (Liu et al. 2014, Mahmoud et al. 2011). The gene discussed is FOXP3; the disease is neoplasm.